Movifast Oral Powder (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet

Movifast is an osmotic purgative containing Polyethylene Glycol 3350 + Electrolytes, manufactured by Ziska Pharmaceuticals Ltd. This oral powder effectively treats constipation in adults and children above 2 years, offering rapid relief by softening stools and enhancing bowel movements.

Available as 8’s pack for ৳200.00 (unit price: ৳25.00/sachet), it balances affordability with efficacy. Each sachet contains 13.125g Macrogol 3350 with electrolytes (350.7mg, 178.5mg, 46.6mg). Store below 30°C without refrigeration to maintain stability.

The drug works via osmotic action, increasing water retention in stools and stimulating intestinal motility. Ideal for fecal impaction treatment, it ensures electrolyte balance through unabsorbed components. Clinical studies confirm negligible systemic absorption, making it safe for pregnancy and breastfeeding.

Dosage guidelines:

• Constipation: 1 sachet daily (dissolved in 125ml water), adjustable up to 3 sachets.
• Fecal impaction: 8 sachets in 1L water consumed within 6 hours; limit use to ≤3 days.

Common side effects include transient diarrhea or abdominal discomfort. Renal-impaired patients require no dose adjustments. Avoid concurrent use with antiepileptics due to reduced drug absorption risks.

Adults & 12+ years: 1 sachet daily in water for constipation. For fecal impaction, dissolve 8 sachets within 6 hours. No dose adjustment needed in renal impairment. Do not use prepared solution beyond 6 hours.

Generally well tolerated. However side effects like allergic reactions, electrolyte disturbances particularly hyperkalaemia and hypokalaemia, abdominal pain, diarrhea, headache, peripheral edema may appear.

Safe in pregnancy (negligible maternal absorption). Compatible with breastfeeding. Use under medical supervision.

Cardiac patients: Do not exceed 2 sachets/hour. Stop immediately if fluid-electrolyte imbalance occurs (edema, dyspnea). Prolonged use may cause dependency.

Use cautiously in elderly. Safe for children (2+ years) at prescribed doses. No renal dose adjustment needed. Limited data in hepatic impairment.

Severe pain or distention can be treated by nasogastric aspiration. Extensive fluid loss by diarrhea or vomiting may require correction of electrolyte disturbances.